CMGE [China Mobile Games & Entertainment] 6-K: CMGE Reports Fourth Quarter and Full Year 2013

[CMGE Reports Fourth Quarter and Full Year 2013 Unaudited Financial Results HONG KONG, March 4, 2014—China Mobile Games and Entertainment Group Limited (“CMGE” or the “Company”) (NASDAQ: CMGE), the largest publisher and a leading developer of mobile games in China, today reported unaudited financial results for the fourth quarter and full year ended December 31, 2013. Fourth Quarter Financial Highlights] [China Mobile Games and Entertainment Group Limited Ken Jian Xiao Director and Chief Executive Officer No. Description Press Release 6-K 1 d685929d6k.htm FORM 6-K]

By | 2016-03-13T02:52:14+00:00 March 4th, 2014|Categories: Chinese Stocks, CMGE, Webplus ver|Tags: , , , , , |0 Comments

DANG [E-COMMERCE CHINA DANGDANG] 6-K: 4Q and FY2013 Press Release February 27, 2014

[4Q and FY2013 Press Release February 27, 2014 Dangdang Announces Fourth Quarter and Fiscal Year 2013 Results Net income in Q4 2013 reached a record RMB21.7 million Gross margin in Q4 2013 expanded 420 basis points year-over-year to 17.6% Total net revenues in Q4 2013 rose 22.1% year-over-year Beijing, China, February 27, 2014 -- E-Commerce China Dangdang Inc. ("Dangdang" or] []

By | 2016-03-21T06:14:43+00:00 March 4th, 2014|Categories: Chinese Stocks, DANG, Webplus ver|Tags: , , , , , |0 Comments

JKS [JinkoSolar] 6-K: JinkoSolar Announces Fourth Quarter and Full Year 2013

[JinkoSolar Announces Fourth Quarter and Full Year 2013 Financial Results SHANGHAI, China, March 3, 2014 - Fourth Quarter 2013 Highlights · Total solar product shipments were 586.3 megawatts (“MW”), consisting of 533.3 MW of solar modules, 7.3 MW of silicon wafers and 45.7 MW of solar cells. This represents an increase of 13.0% from 518.9 MW in the third quarter] []

By | 2016-03-27T07:23:43+00:00 March 4th, 2014|Categories: Chinese Stocks, JKS, Webplus ver|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] SC 13D/A: 16938C106 CUSIP No. 1. Names of Reporting Persons.

[16938C106 CUSIP No. 1. Names of Reporting Persons. WP X Biologics LLC 2. Check the Appropriate Box if a Member of a Group (See Instructions). x ¨ (a) 3. SEC Use Only 4. Source of Funds (See Instructions) WC 5.]

VIMC [Vimicro International] 6-K: Vimicro Updates Fourth-Quarter 2013 Guidance and Provides First-Quarter

[Vimicro Updates Fourth-Quarter 2013 Guidance and Provides First-Quarter 2014 Guidance BEIJING, March 3, 2014 — Vimicro International Corporation (NASDAQ: VIMC) (“Vimicro” or the “Company”), a leading video processor and surveillance solution provider, today updated its guidance for the fourth quarter of 2013 and provided guidance for the first quarter of 2014. The Company now expects total revenues of $21 to] [VIMICRO INTERNATIONAL CORPORATION 15/F Shining Tower Form 20-F x Form 40-F o o o VIMICRO INTERNATIONAL CORPORATION John Zhonghan Deng]

By | 2016-03-22T22:06:27+00:00 March 4th, 2014|Categories: Chinese Stocks, VIMC, Webplus ver|Tags: , , , , , |0 Comments

ATHM [Autohome] SC 13G: JOINT FILING AGREEMENT This Joint Filing Agreement, dated

[JOINT FILING AGREEMENT This Joint Filing Agreement, dated as of March 4, 2014 is by and among Tybourne Capital Management (HK) Limited, Tybourne Capital Management Limited, Tybourne Kesari Limited, and Viswanathan Krishnan (the foregoing are collectively referred to herein as the “Filers”). This Joint Filing Agreement may be terminated by any of the Filers upon one week’s prior written notice] [1 Names of Reporting Persons. TYBOURNE CAPITAL MANAGEMENT (HK) LIMITED 2 Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [ ] 3 SEC Use Only 4]

BONA [Bona Film] CORRESP: Feb. 10, 2014 Attn: Ms. Cvrkel Re: Bona

[Feb. 10, 2014 Attn: Ms. Cvrkel Re: Bona Film Group Ltd. Comment Letter on Form 20F for year ended December 31, 2012 File No. 001-34990 Dear Ms. Cvrkel, If you have any questions or comments, please do not hesitate to direct them to me at 86-10-5631-0849 or amyxu@bonafilm.cn. I am copying Chris Lin, our outside counsel at Simpson Thacher &]

AMC [AMC ENTERTAINMENT] 10-K: FORM 10-K (Mark One) ý For the fiscal

[FORM 10-K (Mark One) ý For the fiscal year ended December 31, 2013 OR o For the transition period from to AMC ENTERTAINMENT HOLDINGS, INC. Delaware 26-0303916 One AMC Way 66211 (913) 213-2000 Title of Each Class Name of Each Exchange on Which Registered Common stock, par value of $0.01 per share None. o ý o ý o ý ý] [FIFTH SUPPLEMENTAL INDENTURE Supplemental Indenture Guarantee Subsidiary Guarantors Subsidiary Guarantor Company This Fifth Supplemental Indenture, dated as of January 15, 2014 (this “ W I T N E S S E T H: Indenture Securities NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Subsidiary Guarantors, the] [THIRD SUPPLEMENTAL INDENTURE Supplemental Indenture Guarantee Subsidiary Guarantors Subsidiary Guarantor” Company This Third Supplemental Indenture, dated as of January 15, 2014 (this “ W I T N E S S E T H: Indenture Securities NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Subsidiary Guarantors, the] [Tax Payment Agreement This Agreement is made and entered into as of October 15, 2013 among Wanda America Investment Holding Co. Ltd (“Wanda”), AMC Entertainment Holdings, Inc. (“AMCEH”) and American Multi-Cinema Inc. (“AMCI”). In consideration of the mutual promises herein, the parties hereto agree as follows: 1. For any period that AMCEH and its subsidiaries (the “AMC Group”) were members] [QuickLinks -- Click here to rapidly navigate through this document AMC ENTERTAINMENT Holdings, INC. AND SUBSIDIARIES (AND JURISDICTION OF ORGANIZATION) AMC Entertainment Holdings, Inc. (Delaware) AMC Entertainment Inc. (Delaware) AMC Europe S.A. (France) LCE AcquisitionSub, Inc. (Delaware) LCE Mexican Holdings, Inc. (Delaware) American Multi-Cinema, Inc. (Missouri) AMC Card Processing Services, Inc. (Arizona) AMC License Services, Inc. (Kansas) AMC ITD, Inc.] [QuickLinks -- Click here to rapidly navigate through this document Consent of Independent Registered Public Accounting Firm The Board of Directors and Stockholders We consent to the incorporation by reference in the registration statement (No. 333-192912) on Form S-8 of AMC Entertainment Holdings, Inc. of our report dated March 4, 2014, with respect to the consolidated balance sheets of AMC] [QuickLinks -- Click here to rapidly navigate through this document CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement (No. 333-192912) on Form S-8 of AMC Entertainment Holdings, Inc. of our report dated March 3, 2014, relating to the financial statements of National CineMedia, LLC, appearing in the Annual Report on Form] [QuickLinks -- Click here to rapidly navigate through this document Consent of Independent Auditor We consent to the incorporation by reference in the registration statement on Form S-8 (File No. 333-192912) of AMC Entertainment Holdings, Inc. of our report dated February 21, 2014, on our audits of the consolidated financial statements of Digital Cinema Implementation Partners, LLC and Subsidiaries as] [QuickLinks -- Click here to rapidly navigate through this document Consent of Independent Registered Public Accounting Firm The Board of Directors and Members We consent to the incorporation by reference in the registration statement (No. 333-192912) on Form S-8 of AMC Entertainment Holdings, Inc. of our report dated February 11, 2014, with respect to the consolidated balance sheets of Open] [QuickLinks -- Click here to rapidly navigate through this document CERTIFICATIONS I, Gerardo I. Lopez, certify that: 1. I have reviewed this annual report on Form 10-K of AMC Entertainment Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the] [QuickLinks -- Click here to rapidly navigate through this document CERTIFICATIONS I, Craig R. Ramsey, certify that: 1. I have reviewed this annual report on Form 10-K of AMC Entertainment Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the] [QuickLinks -- Click here to rapidly navigate through this document CERTIFICATION OF PERIODIC REPORT (1) (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated March 4, 2014 Gerardo I. Lopez Chief Executive Officer, Director and President Craig R. Ramsey Executive Vice President and Chief Financial]

By | 2016-03-26T21:10:45+00:00 March 4th, 2014|Categories: AMC, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

KANG [iKang Healthcare] F-1: SUBJECT TO COMPLETION, DATED , 2014 PRELIMINARY PROSPECTUS

[SUBJECT TO COMPLETION, DATED , 2014 PRELIMINARY PROSPECTUS American Depositary Shares iKang Healthcare Group, Inc. Representing Class A Common Shares This is an initial public offering of American depositary shares, or ADSs, of iKang Healthcare Group, Inc. We are offering ADSs. Each ADS represents Class A common shares, par value US$0.01 per share, of iKang Healthcare Group, Inc. Prior to] [Exclusive Business Cooperation Agreement Agreement PRC This Exclusive Business Cooperation Agreement (hereinafter the “ Party A: ShanghaiMed iKang, Inc. Address: Room 610, Building No. 1, KunTai International Mansion, B12 Chaoyang Men Wai Street, Beijing Party B: Shanghai Guobin Medical Holding Co., Ltd. Address: 15/F, Qianjiang Building, 971 Dongfang Road, Pudong New District, Shanghai Party Parties Party A and Party B] [Equity Pledge Agreement Agreement This Equity Pledge Agreement (the Party A: Pledgee ShanghaiMed iKang, Inc. (the “ Address: 7 th Floor, Haorun Mansion, No. 50, Dengshikou Street, Dongcheng District, Beijing Party B: Pledgor He Boquan (the “ ID No.: 442000601107545 Address: No. 01-02, th Floor, Building A1, Zhong Hai Jin Yuan, Binjiang East Road 957, Guangzhou Pledgor Zhang Ligang (the] [Exclusive Call Option Agreement THIS EXCLUSIVE OPTION AGREEMENT this Agreement PRC March 17th, 2008 Party A: ShanghaiMed iKang, Inc., a wholly foreign-owned enterprise duly organized and validly existing under the laws of China, with its address at 7 th Floor, Haorun Mansion, No. 50, Dengshikou Street, Dongcheng District, Beijing; Party B: No. 01-02, He Boquan, with the Chinese Identification No.] [Power of Attorney No. 01-02, I, He Boquan, with the Identification Card No. 442000601107545 and the address at th Floor, Building A1, Zhong Hai Jin Yuan, Binjiang East Road 957, Guangzhou, being a shareholder of 50% of the equity (“My Equity”) of Shanghai iKang Guobin Group Co., Ltd., (with the former name of “Shanghai Guobin Medical Holding Co., Ltd.”) hereby] [Power of Attorney I, Zhang Ligang, with the Identification Card No. 110105197103200895 and the address at Room 1010, Building 2, Sunshine 100 International Apartment, No. 2 Guanghua Road, Chaoyang District, Beijing, being a shareholder of 50% of the equity (“My Equity”) of Shanghai iKang Guobin Group Co., Ltd., (with the former name of “Shanghai Guobin Medical Holding Co., Ltd.”) hereby] [Exclusive Business Cooperation Agreement Agreement PRC This Exclusive Business Cooperation Agreement (hereinafter the “ Party A: Zhejiang iKang Co., Ltd. Address: 1-3 Party B: Hangzhou iKang Guobin Clinic Co., Ltd. Address: 1-3 Party Parties Party A and Party B are hereinafter individually referred to as a “ WHEREAS, 1. Party A is a wholly-owned subsidiary registered in the PRC of] [Equity Pledge Agreement “Agreement This Equity Pledge Agreement (the Party A: Pledgee Zhejiang iKang Co., Ltd. (the “ 1-3 Party B: Shanghai iKang Guobin Holding Co., Ltd. Address: Room 3182, No. 2123, Pudong Avenue, Shanghai Shanghai Yalong Daoyi Services Co., Ltd. Address: Room 105, Building No. 5, Dongding Plaza, No. 1313, Xizang South Road, Shanghai Pledgors (Shanghai iKang Guobin Holding] [Exclusive Call Option Agreement THIS EXCLUSIVE OPTION AGREEMENT this Agreement PRC Party A: 1-3 Zhejiang iKang Co., Ltd. (WFOE) a wholly-owned subsidiary of a foreign enterprise registered in the British Virgin Islands, with its address at Party B: Shanghai iKang Guobin Holding Co., Ltd., a limited liability company duly organized and validly existing under the laws of the PRC, with] [Power of Attorney Our company, Shanghai iKang Guobin Holding Co., Ltd., with the registered address at Room 3182, No. 2123, Pudong Avenue, Shanghai, being a shareholder of 80% of the equity (“Company Equity”) of Hangzhou iKang Guobin Clinic Co., Ltd., hereby irrevocably authorize Zhejiang iKang Co., Ltd. to exercise the following rights with respect to Company Equity within the term] [Power of Attorney Our company, Shanghai Yalong Daoyi Services Co., Ltd., with the registered address at Room 105, Building No. 5, Dongding Plaza, No. 1313, Xizang South Road, Shanghai, being a shareholder of 20% of the equity (“Company Equity”) of Hangzhou iKang Guobin Clinic Co., Ltd., hereby irrevocably authorize Zhejiang iKang Co., Ltd. to exercise the following rights with respect] [Equity Transfer Contract “Contract” This Equity Transfer Contract (the The Transferor: He Boquan ID No.: 440620196011075452 Address: No. 18, Lane 1, Yinglong Street, Xiaolan Town, Zhongshan City, Guangdong Province The Transferee: Shanghai iKang Guobin Holding Co., Ltd. Address: Room 3182, No. 2123, Pudong Avenue, Shanghai WHEREAS: “Guobin Healthcare Center” 1. Shanghai Guobin Healthcare Center Co., Ltd. ( 2. The Transferor] [Exclusive Business Cooperation Agreement Agreement PRC This Exclusive Business Cooperation Agreement (hereinafter the “ Party A: Yuanhua Medical Consultancy Services (Shanghai) Co., Ltd. Address: 75 Wanping South Road, Room 1801, Shanghai. Party B: Shanghai Yuanhua Information Technology Co., Ltd. Address: 397 Jiaozhou Road, Building 5 Room F206, Jingan District, Shanghai. Party Parties Party A and Party B are hereinafter individually] [Equity Pledge Agreement “Agreement This Equity Pledge Agreement (the Party A: Pledgee Yuanhua Medical Consultancy Services (Shanghai) Co., Ltd. (the “ Address: 75 Wanping South Road, Room 1801, Shanghai Party B: Hu Haiqing Address: 8 Chaoyangmen North Street, Dongcheng District, Beijing Zhao Lei Address: 519 Xinhua Road, Room 28B, Changning District, Shanghai Pledgors (Hu Haiqing and Zhao Lei are collectively] [Exclusive Call Option Agreement THIS EXCLUSIVE OPTION AGREEMENT this Agreement PRC Party A: Yuanhua Medical Consultancy Services (Shanghai) Co., Ltd., a wholly-owned Chinese subsidiary of a enterprise registered in Hong Kong; Party B: Hu Haiqing, whose ID number is 320102198102151619, with his address at 8 Chaoyangmen North Street, Dongcheng District, Beijing; Zhao Lei, whose ID number is 310107196601301213, with his] [Power of Attorney I, Hu Haiqing, with ID number of 320102198102151619, being a shareholder of 80% of the equity (“My Equity”) of Shanghai Yuanhua Information Technology Co., Ltd., hereby irrevocably authorize Yuanhua Medical Consultancy Services (Shanghai) Co., Ltd. to exercise the following rights with respect to My Equity within the term of this Power of Attorney: Yuanhua Medical Consultancy Services] [Power of Attorney I, Zhao Lei, with ID number of 310107196601301213, being a shareholder of 20% of the equity (“My Equity”) of Shanghai Yuanhua Information Technology Co., Ltd., hereby irrevocably authorize Yuanhua Medical Consultancy Services (Shanghai) Co., Ltd. to exercise the following rights with respect to My Equity within the term of this Power of Attorney: Yuanhua Medical Consultancy Services] [Spousal Consent Letter To: ShanghaiMed iKang, Inc I, Baoming Li (ID No. 440620196107155453), legal spouse of Boquan He (ID No. 442000601107545), have acknowledged and carefully read the following agreements signed by Boquan He: Loan Agreement (signed on Jan.12, 2011); Exclusive Call Option Agreement (signed on Mar. 17, 2008); Exclusive Business Cooperation Agreement (signed on Apr. 27, 2007); Power of Attorney] [Spousal Consent Letter To: ShanghaiMed iKang, Inc I, Feiyan Huang (ID No. 110108197010310023), legal spouse of Ligang Zhang (ID No. 110105197103200895), have acknowledged and carefully read the following agreements signed by Ligang Zhang: Loan Agreement (signed on Jan.12, 2011); Exclusive Call Option Agreement (signed on Mar. 17, 2008); Exclusive Business Cooperation Agreement (signed on Apr. 27, 2007); Power of Attorney] [Exclusive Business Cooperation Agreement Agreement PRC This Exclusive Business Cooperation Agreement (hereinafter the “ Party A: Address: th 701, 7 Party B: Address: 708, Tower A, Pengrun Mansion, No. 26 Xiaoyun Road, Chaoyang District, Beijing. Party Parties Party A and Party B are hereinafter individually referred to as a “ WHEREAS, 1. Party A is a wholly-owned subsidiary registered in] [Equity Pledge Agreement Agreement This Equity Pledge Agreement (the “ Party A: Pledgee ShanghaiMed iKang, Inc. (the “ Address: th st 701, 7 Party B: Hu Haiqing (the “Pledgor”) ID Number: 320102198102151619 Party C: Jiandatong Health Technology (Beijing) Co., Ltd. Address: 708, Tower A, Pengrun Mansion, No. 26 Xiaoyun Road, Chaoyang District, Beijing. the Party the Parties For the purpose] [Exclusive Call Option Agreement THIS EXCLUSIVE OPTION AGREEMENT this Agreement PRC Party A: Party B: Party C: Party Parties In this Agreement, Party A, Party B and Party C are referred to as a “ WHEREAS: Party B, Hu Haiqing holds 80% of the equity interest in Party C on behalf of Party A; Party A regularly provides Party C] [Power of Attorney I, Hu Haiqing, with ID number of 320102198102151619, being a shareholder of 80% of the equity (“My Equity”) of Jiandatong Health Technology (Beijing) Co., Ltd., hereby irrevocably authorize ShanghaiMed iKang, Inc. to exercise the following rights with respect to My Equity within the term of this Power of Attorney: ShanghaiMed iKang, Inc. is hereby authorized to act] [Statement and Acknowledgment I, as the shareholder of the 20% equity interest in Jiandatong Health Technology (Beijing) Co., Ltd. (hereinafter referred to as “Company”), hereby state and acknowledge that, in the event that Mr. Hu Haiqing transfers, in whole or in part, the 80% equity interest in the Company held by him to any third party, I agree to such] [Subsidiaries Place of Incorporation 1. iKang Guobin Healthcare Group, Inc. British Virgin Islands 2. Bayley & Jackson (China) Medical Services Limited Hong Kong 3. iKang Zhejiang, Inc. British Virgin Islands 4. Yuanhua Healthcare Limited Hong Kong 5. ShanghaiMed iKang, Inc. People’s Republic of China 6. Shanghai iKang Co., Ltd. People’s Republic of China 7. iKang Health Management (Zhejiang) Co., Ltd.] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in this Registration Statement on Form F-1 of our report dated December 4, 2013 relating to the consolidated financial statements of iKang Guobin Healthcare Group, Inc., its subsidiaries, its variable interest entities (“VIEs”), and its VIEs’ subsidiaries as of and for the years ended March 31, 2011, 2012] [Form of PRC Legal Opinion [ — ] To: iKang Guobin Healthcare Group, Inc. (the “Company”) B-6F, Shimao Tower 92A Jianguo Road, Chaoyang District Beijing 100022, People’s Republic of China Re: Legal Opinion PRC We are qualified lawyers of the People’s Republic of China (the “ Offering ADSs Registration Statement Commission We have acted as PRC counsel for the Company] [February 27, 2014 iKang Healthcare Group, Inc. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People’s Republic of China Consent of Frost & Sullivan “Registration Statement” “Company” “SEC” SEC Filings “Report” Frost & Sullivan hereby consents to references to its name in the Registration Statement on Form F-1 (together with any amendments thereto, the Frost & Sullivan (Beijing)]

Skip to toolbar